Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Michael Stalvey
Associate Professor
Close
E-mail
mstalvey@uab.edu
Links
Provider Directory
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Michael Stalvey
Associate Professor
Positions
Scientist (C)
,
Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center (CAMBAC)
,
School of Medicine
Scientist (C)
,
Comprehensive Diabetes Center
,
School of Medicine
Associate Scientist (C)
,
Cystic Fibrosis Research Center
,
School of Medicine
Associate Professor (S)
,
Dept of Medical Education
,
School of Medicine
Associate Professor (P)
,
Pediatric - Endocrinology
,
Pediatrics
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2022
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis A Clinical Trial
.
American Journal of Respiratory and Critical Care Medicine
. 205:529-539.
2022
2022
Bone mineral density screening by DXA for people with cystic fibrosis: A registry analysis of patient and program factors influencing rates of screening
.
Journal of Cystic Fibrosis
.
2022
2022
Exploring provider attitudes and perspectives related to men's health in cystic fibrosis
.
Journal of Cystic Fibrosis
.
2022
2022
Men's sexual and reproductive health in cystic fibrosis in the era of highly effective modulator therapies–A qualitative study
.
Journal of Cystic Fibrosis
.
2022
2021
Most short children with cystic fibrosis do not catch up by adulthood
.
Nutrients
. 13.
2021
2021
Men's health in the modern era of cystic fibrosis
.
Journal of Cystic Fibrosis
. 20:e121-e123.
2021
2021
Barriers to retinopathy screening in youth and young adults with type 1 diabetes
.
Pediatric Diabetes
. 22:469-473.
2021
2021
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy
.
Journal of Cystic Fibrosis
. 20:205-212.
2021
2021
Real-World Screening for Retinopathy in YouthWith Type 1 Diabetes Using a Nonmydriatic Fundus Camera
.
Diabetes Spectrum
. 34:27-33.
2021
2019
Growth failure and treatment in cystic fibrosis
.
Journal of Cystic Fibrosis
. 18:S82-S87.
2019
2017
Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat
.
PLoS ONE
. 12.
2017
2017
Effects of diagnosis by newborn screening for cystic fibrosis on weight and length in the first year of life
.
JAMA Pediatrics
. 171:546-554.
2017
2017
Growth in prepubertal children with cystic fibrosis treated with ivacaftor
.
Pediatrics
. 139.
2017
2013
Cystic fibrosis-related bone disease: Insights into a growing problem
2013
2013
Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease
.
PLoS ONE
. 8.
2013
2012
A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis
.
Pediatric Pulmonology
. 47:252-263.
2012
2009
Endocrine parameters of cystic fibrosis: Back to basics
.
Journal of Cellular Biochemistry
. 108:353-361.
2009
2009
Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation
.
Pediatric Research
. 65:311-316.
2009
2008
CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes
.
Cytokine
. 44:154-159.
2008
2008
Growth hormone therapy improves growth in children with cystic fibrosis related liver disease
.
Journal of Pediatric Endocrinology and Metabolism
. 21:793-797.
2008
2007
A long-term evaluation of the juvenile diabetic
.
Journal of Pediatrics
. 150:105.
2007
2006
Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after β-cell injury
.
Diabetes
. 55:1939-1945.
2006
2005
Diabetes acceleration or prevention by a coxsackievirus B4 infection: Critical requirements for both interleukin-4 and gamma interferon
.
Journal of Virology
. 79:1045-1052.
2005
2004
Predictors of control of diabetes: Monitoring may be the key
.
Journal of Pediatrics
. 144:660-661.
2004
1995
Blepharophimosis syndrome is linked to chromosome 3q
.
Human Molecular Genetics
. 4:443-448.
1995
Research
Principal Investigator On
A Prospective Study to Evaluate Effects of Corrected CFTR Function (BEGIN)
awarded by
Cystic Fibrosis Foundation ^
BEGIN Sub-study – Continuous Glucose Monitoring in Healthy Children
awarded by
Cystic Fibrosis Foundation ^
Baby and Early Childhood Endocrine Factors and Growth in Cystic Fibrosis (BEGIN) Study
awarded by
Cystic Fibrosis Foundation ^
CFTR and the CF Rat Islet: A Novel Model for the Study of CFRD
awarded by
Cystic Fibrosis Foundation ^
Characterization of Glucose Regulation in the CFTR Knockout Rat
awarded by
KAUL PEDIATRIC RESEARCH INSTITUTE
First and Second Year Clinical Fellowship
awarded by
Cystic Fibrosis Foundation ^
PROMISE-OB-18
awarded by
Cystic Fibrosis Foundation ^
Private Grant
awarded by
VERSARTIS INC.
Private Grant
awarded by
VERSARTIS INC.
Private Grant
awarded by
NOVO NORDISK PHARMACEUTICALS, INC.
Private Grant
awarded by
NOVO NORDISK PHARMACEUTICALS, INC.
Private Grant
awarded by
ASCENDIS PHARMA A/S
Private Grant
awarded by
LUMOS PHARMA INC.
Role of Body Fat Distribution in Metabolic and Pulmonary Decline in CF
awarded by
Emory University
The Effects of CFTR Deficiency on Metabolic Bone Disease
awarded by
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
Investigator On
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Private Grant
awarded by
OPKO BIOLOGICS LTD
Private Grant
awarded by
ASCENDIS PHARMA A/S
Private Grant
awarded by
ASCENDIS PHARMA A/S
Private Grant
awarded by
ASCENDIS PHARMA A/S
UAB CF Research and Translation Core Center
awarded by
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
UAB CF Research and Translation Core Center
awarded by
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
UAB CF Research and Translation Core Center - Pilot & Feasibility
awarded by
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
UAB CF Research and Translation Core Center - Pilot and Feasibility
awarded by
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
Background
Education And Training
University of Florida - Gainesville, Internship
University of Florida - Gainesville, Residency
University of Florida - Gainesville, Postdoctoral Fellowship
Doctor of Medicine,
University of Florida
1999
Bachelor of Science or Mathematics in Zoology / Animal Biology,
University of Florida
1992
Contact
Full Name
Michael
Stalvey